Evidence map›Paper›PMID 42326659›Full record

ArticleACS omega2026

Deciphering O‑GlcNAc-Dependent Signaling Via Integrated Proteomics and Phosphoproteomics.

Ci Wu, Chunyan Hou, Xinyue Wang, Yihan Peng, Yao Lin, Stephen W Byers, Huadong Pei, Junfeng Ma

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ci WuDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, United States.
Chunyan HouDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, United States.ORCID https://orcid.org/0000-0001-5966-1899
Xinyue WangSchool of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China.
Yihan PengDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, United States.
Yao LinSchool of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China.
Stephen W ByersDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, United States.
Huadong PeiDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, United States.
Junfeng MaDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, United States.ORCID https://orcid.org/0000-0002-5183-5425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications (PTMs) on proteins play crucial roles in various biological processes. Two highly dynamic modifications, phosphorylation and O-linked N-acetylglucosamine modification (O-GlcNAcylation), are essential for cellular physiology and pathology. Emerging evidence suggests intimate crosstalk between phosphorylation and O-GlcNAcylation on multiple proteins. However, the precise nature of their crosstalk remains largely unknown. In this study, we explored the crosstalk between phosphorylation and O-GlcNAcylation using the pancreatic ductal cell line PANC-1 as a model. Proteome and phosphoproteome changes were measured for cells treated with OSMI-1, a specific inhibitor of O-GlcNAc transferase, and Thiamet G, a specific inhibitor of O-GlcNAcase. Among the 8938 phosphorylation sites quantified, 2289 phosphosites on 1225 proteins and 2201 phosphosites on 1199 proteins were significantly altered by OSMI-1 and TMG treatment, respectively, demonstrating extensive crosstalk between O-GlcNAcylation and phosphorylation. Further analysis revealed widespread phosphorylation changes of the kinome and phosphatome, even after a short-term perturbation with inhibitors to O-GlcNAc cycling enzymes. Moreover, phosphoproteomic profiling, kinase inhibition experiments, and in vitro kinase assays identified that phosphorylation of OGA itself at S364 is specifically mediated by casein kinase 2 α (CK2α). These results uncover glycosylation-dependent cellular signaling through the potentially multilayer crosstalk between phosphorylation and O-GlcNAcylation.

Identifiers

PMID42326659
PMCPMC13280846

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.